Blaze is a no-code application development platform designed for building secure, compliant software quickly. It enables users to create complex workflows, integrate with various data sources and APIs, and deploy custom solutions without writing code. The platform emphasizes security, offering certifications like HITRUST, making it suitable for regulated industries such as healthcare.

Conceivable Life Sciences operates the world's first fully automated IVF lab, utilizing AI-powered automation to perform over 200 steps in embryo creation. This technology addresses the limited access to IVF by scaling production, improving success rates, and reducing costs, enabling more individuals to benefit from fertility treatments.

Empatica develops FDA-cleared wearable devices and a health monitoring platform that continuously collects clinical-quality health data and digital biomarkers from everyday life. This technology enables researchers and clinicians to monitor conditions such as epilepsy and movement disorders, enhancing data collection for clinical trials and real-world health insights.

FlyteHealth offers a technology‑enabled obesity and cardiometabolic care program for large employers, insurers, and government health plans. The service provides remote physician‑supervised, prescription‑grade pharmacotherapy, digital coaching, and continuous outcome monitoring through a HIPAA‑compliant platform, while analytics quantify cost avoidance and ROI for the covered population.

H Company develops AI models, including VLMs and LLMs, to automate web processes and enhance decision-making for businesses. Their technology increases worker productivity by streamlining repetitive tasks and improving operational efficiency.

Hyro provides a conversational AI platform that automates over 85% of repetitive patient interactions through voice and text capabilities, enhancing operational efficiency in healthcare settings. By integrating with existing digital channels, Hyro reduces staff workload and improves patient support, achieving a 98% accuracy rate in responses.

Optellum develops AI-based decision support software that utilizes imaging biomarkers to enhance the early detection of lung cancer. This technology enables clinicians to identify at-risk patients and optimize their management strategies, improving patient outcomes in lung health care.

Outpace Bio utilizes AI-powered protein design to engineer novel biological functions for cell therapies. The company develops platform technologies like OUTSPACER™, OUTSMART™, and OUTLAST™ to enhance the potency, persistence, and safety of these treatments against solid tumors. This approach programs engineered cells to make optimal decisions within the tumor microenvironment to achieve durable clinical responses.

Parasail provides scalable, high-performance AI compute for open-source models, enabling enterprises to deploy and optimize workloads like retrieval-augmented generation and multimodal processing. The platform reduces costs and complexity by offering serverless APIs, dedicated hardware, and automated tuning, achieving up to 10x cost savings while ensuring efficient batch and real-time processing.